Abstract
Use of serum alpha-fetoprotein (AFP) in clinical practices has been challenged in recent years, due to the lack of specificity and sensitivity. Here we conducted a retrospective study to evaluate the diagnostic and prognostic value of serum AFP among hepatocellular carcinoma (HCC) patients with their pathogenic features taken into consideration. The cohort for this study comprised 318 cases of hepatitis and 731 cases of cirrhosis, as well as 796 HCC patients. Using 11.62ng/mL as a cut-off value, the positive rate of AFP test among serum hepatitis B surface antigen (HBsAg) positive HCC patients was significantly higher than that in those HBsAg negative HCC patients (79.55% vs 56.49%, P < 0.000). Similarly, the median serum AFP level in HCC patients with serum HBsAg positive was significantly higher than that in those HBsAg negative HCC patients (423.89ng/ml vs 40.82ng/ml, P < 0.000). In addition, Kaplan-Meier curve analysis revealed that lower preoperative AFP level implicated a much higher overall survival rate. Of note, such prognosis predicting value was only seen in those chronic HBV infection-related HCC patients, but not among the HCC patients etiologically irrelevant to HBV infection. We believe that serum AFP is of diagn...Continue Reading
References
Apr 23, 2009·Journal of Gastroenterology and Hepatology·Deepak AmarapurkarUNKNOWN Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
Nov 21, 2009·Alimentary Pharmacology & Therapeutics·R Cabrera, D R Nelson
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Feb 9, 2012·Journal of Hepatology·Marta BurrelJordi Bruix
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Mar 23, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hie-Won HannHushan Yang
Oct 31, 2012·Korean Journal of Pathology·Hae Yoen JungKyoung-Bun Lee
Dec 6, 2012·Cancer Letters·Mengsen LiShaojiang Zheng
Apr 5, 2013·World Journal of Gastroenterology : WJG·Chang LiuJia-Yin Yang
Oct 15, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Grace L H WongVincent W S Wong
Jul 16, 2014·Gut·Giuliana AmaddeoJessica Zucman-Rossi
Apr 8, 2015·International Journal of Cancer. Journal International Du Cancer·Chao ZhangGang Li
Citations
Jan 23, 2020·International Journal of Epidemiology·A Cecile J W Janssens, Forike K Martens
Oct 30, 2019·Journal of Clinical Laboratory Analysis·Heping ZhaoYing Guo
Apr 15, 2017·Oncotarget·Liyun FuJunming Guo
Apr 19, 2017·Oncotarget·Xiwen LiaoTao Peng
Feb 6, 2017·Oncotarget·Tianhui LiuFengmin Lu
Apr 9, 2016·Oncotarget·Xunjun YangJianxin Lyu
Nov 12, 2016·Oncotarget·Nan ZhangXia He
Jan 19, 2018·Oncology Letters·Biqiong RenPing Yu
Jan 15, 2019·Journal of Clinical and Translational Hepatology·Xiajie WenFengmin Lu
Jun 27, 2020·Frontiers in Pharmacology·Yang AnXiangqian Guo
Oct 13, 2016·World Journal of Gastroenterology : WJG·Stijn Van HeesThomas Vanwolleghem
Jun 6, 2019·Frontiers in Oncology·Minjun LiaoWeijia Liao
Jun 7, 2017·Scientific Reports·Yongzhen LiuFengmin Lu
Jul 11, 2020·BMC Gastroenterology·Chyntia Olivia Maurine JasirwanImelda Loho
Jun 28, 2017·Lipids in Health and Disease·Lu TianWei Guo
Sep 1, 2018·Molecular Biology Reports·Gyeong Im YuJae Seok Hwang
Apr 16, 2021·The Cochrane Database of Systematic Reviews·Agostino ColliGiovanni Casazza
Jul 10, 2020·Gastroenterology·Xiajie WenFengmin Lu
Jul 27, 2021·Medical Journal, Armed Forces India·Mohamed EissaSalah Rozaik
Dec 24, 2018·Langmuir : the ACS Journal of Surfaces and Colloids·Lele ZhouLi Yu
Oct 2, 2020·Liver Cancer·Chia-Jui YenYoon-Koo Kang